Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of antagonists of the CBI receptor for the manufacture of a composition useful for the treatment of hepatic diseases

Use of antagonists of the CBI receptor for the manufacture of a composition useful for the treatment of hepatic diseases

US Patent 8604060 · Granted Dec 10, 2013

Estimated economic value: $13,086,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and pharmaceutical compositions for the treatment of fibrosis2018
Selective inhibitors of CB2 receptor expression and/or activity for the treatmen2013
Selective inhibitors of CB2 receptor expression and/or activity for the treatmen2013
Use of antagonists of the CB1 receptor for the manufacture of a composition usef2012
Use of antagonists of the CB1 receptor for the manufacture of a composition usef2012
Use of antagonists of the CB1 receptor for the manufacture of a composition usef2012
Use of antagonists of the CB1 receptor for the manufacture of a composition usef2012
Method of treating insulin resistance with a selective inhibitor of CB2 receptor2011
Method of treating insulin resistance with a selective inhibitor of CB2 receptor2011
CB2 receptors blocks accumulation of human hepatic myofibroblasts: a novel antif2011
CB2 receptors blocks accumulation of human hepatic myofibroblasts: a novel antif2011
CB2 receptors blocks accumulation of human hepatic myofibroblasts: a novel antif2011